Corcept Therapeutics Quote - 0I3Q

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

18.23

Bid

0.00

Ask

0.00

Volume

1,415

0.00 Day's Range 0.00

18.23 52 Week Range 18.23

Market Cap

1.879B

Previous Close

18.23

Open

Last Trade

50.31

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

3,364

Shares Outstanding

103,081,000

Dividend Yield

PE Ratio

50.22

Earnings Per Share (EPS)

1.03

Revenue

482.38M

Net Profit

106.14M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.corcept.com

Headquarters

Wilmington, Delaware, USA

Founded

Corcept Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0I3Q. The last closing price for Corcept Therapeutics was US$18.23. Over the last year, Corcept Therapeutics shares have traded in a share price range of US$ 18.23 to US$ 18.23.

Corcept Therapeutics currently has 103,081,000 shares outstanding. The market capitalization of Corcept Therapeutics is US$1.88 billion. Corcept Therapeutics has a price to earnings ratio (PE ratio) of 50.22.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	18.23	18.23	18.23	391	18.23	DE
4	18.23	18.23	18.23	790	18.23	DE
12	18.23	18.23	18.23	3364	18.23	DE
26	18.23	18.23	18.23	1763	18.23	DE
52	18.23	18.23	18.23	1325	18.23	DE
156	18.23	18.23	18.23	590	18.23	DE
260	18.23	18.23	18.23	723	18.23	DE

0I3Q - Frequently Asked Questions (FAQ)

What is the current Corcept Therapeutics share price?

The current share price of Corcept Therapeutics is US$ 18.23

How many Corcept Therapeutics shares are in issue?

Corcept Therapeutics has 103,081,000 shares in issue

What is the market cap of Corcept Therapeutics?

The market capitalisation of Corcept Therapeutics is USD 1.88B

What is the 1 year trading range for Corcept Therapeutics share price?

Corcept Therapeutics has traded in the range of US$ 18.23 to US$ 18.23 during the past year

What is the PE ratio of Corcept Therapeutics?

The price to earnings ratio of Corcept Therapeutics is 50.22

What is the cash to sales ratio of Corcept Therapeutics?

The cash to sales ratio of Corcept Therapeutics is 11.05

What is the reporting currency for Corcept Therapeutics?

Corcept Therapeutics reports financial results in USD

What is the latest annual turnover for Corcept Therapeutics?

The latest annual turnover of Corcept Therapeutics is USD 482.38M

What is the latest annual profit for Corcept Therapeutics?

The latest annual profit of Corcept Therapeutics is USD 106.14M

What is the registered address of Corcept Therapeutics?

The registered address for Corcept Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Corcept Therapeutics website address?

The website address for Corcept Therapeutics is www.corcept.com

Which industry sector does Corcept Therapeutics operate in?

Corcept Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SCGLSealand Capital Galaxy Limited	3.25p (103.13%)	12.18M
BORBorders & Southern Petroleum Plc	3.64p (51.04%)	23.81M
NEONeo Energy Metals Plc	0.95p (22.58%)	37.84M
GNIPGenip Plc	32.00p (20.75%)	192.82k
ZIOCZanaga Iron Ore Company Limited	10.50p (19.86%)	2.84M
DGIDg Innovate Plc	0.02p (-20.00%)	298.54M
SNGSynairgen Plc	2.10p (-19.39%)	1.67M
VRSVersarien Plc	0.03p (-18.92%)	103.72M
QEDQuadrise Plc	5.90p (-17.83%)	17.66M
ZENZenith Energy Ltd.	4.90p (-16.24%)	1.48M
SYMESupply@me Capital Plc	0.0042p (12.00%)	1.19B
MSMNMosman Oil And Gas Limited	0.035p (12.90%)	654.48M
TRPTower Resources Plc	0.0395p (0.00%)	570.56M
CPXCap-xx Limited	0.1775p (-2.74%)	379.2M
NTVONativo Resources Plc	0.0019p (-5.00%)	312.89M